APGE - Apogee Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$130.92
DETAILS
HIGH:
$140.00
LOW:
$89.00
MEDIAN:
$135.00
CONSENSUS:
$130.92
DOWNSIDE:
3.07%
Institutional Holders (13F)
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-08-07 | Fairmount Funds Management LLC | director | M-Exempt | 10,370 | $43.85 | $455K |
| 2026-08-07 | Fairmount Funds Management LLC | director | M-Exempt | 31,838 | $17.00 | $541K |
| 2026-08-05 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 5,500 | $134.17 | $738K |
| 2026-08-05 | Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4,125 | $22.86 | $94K |
| 2026-07-24 | Henderson Jane | officer: Chief Financial Officer | G-Gift | 15,000 | -- | -- |
| 2026-07-14 | Dambkowski Carl | officer: Chief Medical Officer | G-Gift | 8,000 | -- | -- |
| 2026-07-08 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 20,000 | $133.63 | $2.7M |
| 2026-07-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | G-Gift | 75,046 | -- | -- |
| 2026-07-01 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 5,500 | $132.74 | $730K |
| 2026-07-01 | Dambkowski Carl | officer: Chief Medical Officer | M-Exempt | 4,125 | $22.86 | $94K |
| 2026-06-22 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 26,400 | $132.60 | $3.5M |
| 2026-06-22 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 80,000 | $132.54 | $10.6M |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 2,305 | $86.27 | $199K |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 614 | $86.89 | $53K |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 7,654 | $82.78 | $634K |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 6,770 | $82.21 | $557K |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 1,577 | $85.19 | $134K |
| 2026-06-10 | HENDERSON MICHAEL THOMAS | director, officer: Chief Executive Officer | SELL | 1,080 | $84.18 | $91K |
| 2026-06-09 | Bollinger Lisa | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-09 | Shah Nimish P | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-09 | McKenna Mark C. | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-09 | JONES WILLIAM A JR | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-09 | Fox Jennifer A. | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-09 | Fairmount Funds Management LLC | director | A-Award | 7,657 | $85.00 | $651K |
| 2026-06-03 | Dambkowski Carl | officer: Chief Medical Officer | SELL | 5,500 | $78.71 | $433K |